the aid library

LIST OPTIONS

Filter

851

Download (218)

View PDF (256)

HIV and AIDS in India

Avert (2018) C2

Download (167)

View PDF (208)

Cascade of care among HIV patients diagnosed in 2013 in Georgia: Risk factors for late diagnosis and attrition from HIV care

E. Ruadze; N. Chkhartishvili; O. Chokoshvili; T. Tsertsvadze SAGE Open Medicine (2017) C2

Original Article SAGE Open Medicine Volume 5: 1–7 © The Author(s) 2017 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav httpDs:O//dIo: i1.o0r.g1/107.171/2770/52035013212171773311977 journals.sagepub.com/home/smo

Download (185)

View PDF (253)

The ACT-Accelerator: Two years of impact

World Health Organization WHO (2022) C_WHO

The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.

Download (185)

View PDF (204)

Exhortation Apostolique Evangelii Gaudium du Saint-Père Francois

Saint-Pere Francois Libraire Vaticane (2013) CC

EXHORTATION APOSTOLIQUE EVANGELII GAUDIUMDU SAINT-PÈRE FRANÇOIS AUX ÉVÊQUES AUX PRÊTRES ET AUX DIACRESAUX PERSONNES CONSACRÉES ET À TOUS LES FIDÈLES LAÏCS SUR L’ANNONCE DE L’ÉVANGILE DANS LE MONDE D’AUJOURD’HUI

Download (186)

View PDF (257)

Evaluation of COVID-19 vaccine effectiveness in a changing landscape of COVID-19 epidemiology and vaccination

World Health Organization WHO (2022) C_WHO

Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method... more

Download (2288)

View PDF (2564)

Treatment of Mycobacterium Ulcerans Disease (Buruli Ulcer)
recommended

World Health Organization WHO WHO (2012) C_WHO

Guidance for health workers

Download (1994)

View PDF (4138)

Polio Laboratory Manual

World Health Organization (2004) C_WHO

Download (452)

View PDF (336)

Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice
recommended

International Union Against Tuberculosis and Lung Disease (2019) C1

The 7th edition of the Orange Guide provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens

Download (540)

View PDF (1026)

Nigeria: National Nutritional Guideline On Non-Communicable Disease Prevention, Control and Management

Federal Ministry of Health, Nigeria (2014) C1

Download (809)

View PDF (1520)

Antiretroviral Therapy Guidelines for HIV-Infected Adults and Adolescents Including Post-exposure Prophylaxis

Ministry of Health & Family Welfare Government of India Ministry of Health & Family Welfare Government of India (2007) C1

Download (543)

View PDF (509)

Rwanda: GUIDE DE PRISE EN CHARGE DE LA TUBERCULOSE MULTIRESISTANTE

Ministere de la Sante & Rwanda Biomedical Centre (2012) C2

Le présent manuel fournit les directives actualisées à l'intention des médecins, infirmiers et laborantins confrontés à la tuberculose multirésistante (TB-MR). Il remplace la version élaborée en 2007 et s’est enrichi de l’expérience pratique de six années. Il s’appuie sur les recomm... more

Download (537)

View PDF (378)

An Assessment of Available Evidence on NCDs and their Risk Factors in Myanmar

HelpAge International Myanmar, University of Public Health and University of Medicine-2 (2016) C1

Report on Main Findings
The review encompasses three complementary components: 1) a review of published literature 2000-2015 on NCDs and their risk factors; 2) qualitative interviews with key actors engaged in NCD research in Myanmar; and 3) additional reviews of Myanmar ethical committee inqui... more

Download (182)

View PDF (217)

Toolkit for research and development of paediatric antiretroviral drugs and formulations

World Health Organization (WHO); Unitaid; Unicef; et al. World Health Organization (WHO); Unitaid; Unicef; et al. (2018) C_WHO

WHO and UNITAID in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group

Download (276)

View PDF (256)

Manuel sur le sida pédiatrique en Afrique
recommended

Tindyebwa, D.; J. Kayita, P. Musoke et. al. Réseau africain pour les soins aux enfants affectés par le sida (ANECCA) (2017) C2

Ce manuel donne une vue d’ensemble des connaissances scientifiques actuelles sur l’infection à VIH ainsi que des technologies et des outils utilisés pour prévenir cette infection, pour améliorer la qualité de vie des personnes infectées et pour réduire les effets du VIH sur les enfants et... more

Download (173)

View PDF (196)

Plan stratégique de la santé de la réproduction 2012-2015

République du Sénégal ministère de la santé, de l'hygiene publique et de la prévention direction de la santé, division de la santé de la réproduction (2010) C2

Accessed on 02.02.2020 Selon la Conférence Internationale sur la Population et le Développement (CIPD, Caire, 94, paragraphe 7.2), « la santé de la reproduction ou santé génésique est un état de complet bien-être physique, mental et social et pas seulement l’absence de maladie ou d’inf... more

Download (203)

View PDF (224)

Antimicrobial movement from agricultural areas to the environment: The missing link

Jackson, J., Kheng Heng, L., Eklund, G. et al. Food and Agriculture Organization (FAO) (2019) C2

A role for nuclear techniques Antimicrobials play a critical role in the treatment of human and animal (aquatic and terrestrial) diseases, which has led to their widespread application and use. Antimicrobial resistance (AMR) is the ability of microorganisms to stop an antibiotic, such as an antimic... more

Download (231)

View PDF (314)

Initiativthema „One Health“ in der Entwicklungszusammenarbeit

Bundesministerium für wirtschaftliche Zusammenarbeit und Entwicklung BMZ (2021) CC

BMZ Papier 1 Gesundheit ist nicht nur Voraussetzung für ein selbstbestimmtes Leben, sondern auch essenziell für die gesellschaftliche und nachhaltige wirtschaftliche Entwicklung in unseren Partnerländern. Die gegenwärtige COVID-19 Pandemie zeigt, welche Gefahren von Infektionskrankheiten ausge... more

Download (183)

View PDF (209)

Enquêtes par sites sentinelles sur la résistance acquise du VIH au dolutégravir chez les personnes sous traitement antirétroviral incluant ce médicament

World Health Organisation (WHO) (2023) C_WHO

Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les populations sous TAR. Bien que la résistance au DT... more

Download (214)

View PDF (219)

Human African trypanosomiasis. Seminar

Büscher P., Cecchi G., Jamonneau V. et al (2017) C2

The Lancet Volume 390, Issue 10110p2397-2409November 25, 2017. Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to death, unless treatment is provided. HAT caused devastating epidemics during the 20th century. Thanks to ... more

Download (103)

View PDF (94)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Treatment of Mycobacterium Ulcerans Disease (Buruli Ulcer) recommended

Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice recommended

Manuel sur le sida pédiatrique en Afrique recommended

Treatment of Mycobacterium Ulcerans Disease (Buruli Ulcer)
recommended

Management of Tuberculosis: A Guide to the Essentials of Good Clinical Practice
recommended

Manuel sur le sida pédiatrique en Afrique
recommended